Evidence map›Paper›PMID 41624723›Full record

ArticleACS physical chemistry Au2026

Acetaldehyde as CH

Davide Corinti, Daniël B Rap, Sandra Brünken, Marius Gerlach, Barbara Chiavarino, Simonetta Fornarini, Paul Mayer, Maria Elisa Crestoni

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS physical chemistry Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Davide CorintiDipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, P. le A. Moro 5, Roma I-00185, Italy.ORCID https://orcid.org/0000-0001-8064-3492
Daniël B RapHFML-FELIX, Toernooiveld 7, Nijmegen 6525 ED, The Netherlands.
Sandra BrünkenHFML-FELIX, Toernooiveld 7, Nijmegen 6525 ED, The Netherlands.ORCID https://orcid.org/0000-0001-7175-4828
Marius GerlachHFML-FELIX, Toernooiveld 7, Nijmegen 6525 ED, The Netherlands.ORCID https://orcid.org/0000-0002-7930-8061
Barbara ChiavarinoDipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, P. le A. Moro 5, Roma I-00185, Italy.ORCID https://orcid.org/0000-0002-1585-7061
Simonetta FornariniDipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, P. le A. Moro 5, Roma I-00185, Italy.ORCID https://orcid.org/0000-0002-6312-5738
Paul MayerDepartment of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa K1N6N5, Canada.ORCID https://orcid.org/0000-0001-6112-4398
Maria Elisa CrestoniDipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, P. le A. Moro 5, Roma I-00185, Italy.ORCID https://orcid.org/0000-0002-0991-5034

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The methylene radical cation (CH

Indexed as

astrochemistryC3H6O+• radical cationDFT calculationsion−molecule reactionsIR spectroscopymethylenation

Identifiers

PMID41624723
PMCPMC12856677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.